# RECURSION PHARMACEUTICALS IN (RXRX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 75629V104
Page URL: https://superinvestorclub.com/stock/RXRX
Last updated: 2026-08-29T13:46:47.385Z

## Summary

As of the most recent 13F filing period, RECURSION PHARMACEUTICALS IN (RXRX) is held by 1 tracked superinvestors with an aggregate position value of $138,238 representing 037667 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 37667 | $138,238 | 0.00% | 2026-06-30 |

## Ownership history (quarter-over-quarter)

- 2026-06-30: 1 holders, $138,238 aggregate, 037667 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "RECURSION PHARMACEUTICALS IN (RXRX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/RXRX), aggregating SEC 13F, Form 4, and congressional disclosures."